<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="of Geriatrics: Saving Frail Older People from the SARS-CoV-2 Pandemic" exact="Infection" post="LandiFrancescofrancesco.landi@unicatt.itBarillaroC.BellieniA.BrandiV.CarfìA.D’AngeloM.FuscoD.LandiG.Lo MonacoR.MartoneA.M.MarzettiE.PaganoF.PaisC.RussoA.SaliniS.TosatoM.TummoloA.BenvenutoF.BramatoG.CatalanoL.CiciarelloF.MartisI.RocchiS.RotaE.SalernoA.TrittoM.SgadariA.ZuccalàG.BernabeiR.[], grid.8142.f0000 0001 0941 3192Fondazione Policlinico Universitario &quot;Agostino"/>
 <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
 <result pre="2019, a relevant number of patients affected by a mysterious" exact="pneumonia" post="has been documented in Wuhan, China (1). Around the"/>
 <result pre="end of last year, the causative agent of this unexplained" exact="pneumonia" post="has been identified as a new coronavirus. This virus"/>
 <result pre="a new coronavirus. This virus has been &quot;baptized&quot; as severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) and the relative disease"/>
 <result pre="new coronavirus. This virus has been &quot;baptized&quot; as severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) and the relative disease has"/>
 <result pre="coronavirus. This virus has been &quot;baptized&quot; as severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) and the relative disease has been"/>
 <result pre="severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the relative" exact="disease" post="has been called as coronavirus disease 2019 (COVID-19) by"/>
 <result pre="2 (SARS-CoV-2) and the relative disease has been called as" exact="coronavirus disease" post="2019 (COVID-19) by the World Health Organization. The COVID-19"/>
 <result pre="(SARS-CoV-2) and the relative disease has been called as coronavirus" exact="disease" post="2019 (COVID-19) by the World Health Organization. The COVID-19"/>
 <result pre="in China and all over the world now as pandemic" exact="infection" post="(1). The aim of this review is primarily to"/>
 <result pre="strategies, and the role of the geriatrician in managing this" exact="infection" post="emergency. SARS-CoV-2 infection The pathogen that causes COVID-19 disease"/>
 <result pre="role of the geriatrician in managing this infection emergency. SARS-CoV-2" exact="infection" post="The pathogen that causes COVID-19 disease is a new"/>
 <result pre="this infection emergency. SARS-CoV-2 infection The pathogen that causes COVID-19" exact="disease" post="is a new coronavirus that has been isolated in"/>
 <result pre="characteristics, the envelope spike (S) protein is really important for" exact="infectious" post="mechanism of coronavirus. This S protein facilitates receptor binding"/>
 <result pre="(6). Epidemiology The World Health Organization (WHO) has declared COVID-19" exact="disease" post="a public health emergency of international concern. Even though"/>
 <result pre="of multiple pre-existing comorbidities is related with more severe COVID-19" exact="infection" post="manifestation, reflecting the presence of pre-existent physical and/or cognitive"/>
 <result pre="and/or cognitive frailty. It is now evident that the COVID-19" exact="disease" post="vulnerable and dying population encompasses the older persons and"/>
 <result pre="older persons and people with underlying medical conditions (such as" exact="cardiovascular" post="diseases, diabetes mellitus, renal failure, respiratory diseases), which needs"/>
 <result pre="and people with underlying medical conditions (such as cardiovascular diseases," exact="diabetes mellitus," post="renal failure, respiratory diseases), which needs more attention and"/>
 <result pre="with underlying medical conditions (such as cardiovascular diseases, diabetes mellitus," exact="renal failure," post="respiratory diseases), which needs more attention and care (8,9)."/>
 <result pre="medical conditions (such as cardiovascular diseases, diabetes mellitus, renal failure," exact="respiratory" post="diseases), which needs more attention and care (8,9). Recent"/>
 <result pre="there is the highest proportion of older patients with COVID-19" exact="disease" post="and that the rate of older people may partially"/>
 <result pre="the case-fatality rates observed among countries. Overall, deaths for COVID-19" exact="infection" post="are largely detected among older, male patients who at"/>
 <result pre="the same time have multiple comorbidities. Mitigation strategy for SARS-CoV-2" exact="infection" post="is indispensable to allow optimal care for all patients"/>
 <result pre="demographics. Clinical features The range of clinical presentations of COVID-19" exact="disease" post="have been described varying from asymptomatic infection to severe"/>
 <result pre="presentations of COVID-19 disease have been described varying from asymptomatic" exact="infection" post="to severe respiratory failure (10). The common clinical manifestations"/>
 <result pre="disease have been described varying from asymptomatic infection to severe" exact="respiratory" post="failure (10). The common clinical manifestations include fever, cough,"/>
 <result pre="headache. In addition, patients may have also gastrointestinal symptoms, with" exact="diarrhea" post="and vomiting. Some patients may have taste and smell"/>
 <result pre="patients may have taste and smell disturbances, too. While interstitial" exact="pneumonia" post="is present in most COVID- 19 disease patients, pleuritic"/>
 <result pre="too. While interstitial pneumonia is present in most COVID- 19" exact="disease" post="patients, pleuritic chest pain is present in only few"/>
 <result pre="pneumonia is present in most COVID- 19 disease patients, pleuritic" exact="chest" post="pain is present in only few cases. Based on"/>
 <result pre="mild, severe, and critical types (11). Mild patients had non" exact="pneumonia" post="or mild pneumonia with moderate signs and symptoms. Severe"/>
 <result pre="critical types (11). Mild patients had non pneumonia or mild" exact="pneumonia" post="with moderate signs and symptoms. Severe patients had numerous"/>
 <result pre="non pneumonia or mild pneumonia with moderate signs and symptoms." exact="Severe" post="patients had numerous clinical symptoms, including fever and cough,"/>
 <result pre="including fever and cough, blood oxygen saturation less than 94%," exact="partial" post="pressure of arterial oxygen to fraction of inspired oxygen"/>
 <result pre="oxygen to fraction of inspired oxygen ratio less than 300," exact="respiratory" post="frequency of 30 or more acts per minute, and/"/>
 <result pre="more than 50%. Finally, critical patients had severe conditions, such" exact="respiratory" post="failure, septic shock, and/or multiple organ dysfunction or failure."/>
 <result pre="50%. Finally, critical patients had severe conditions, such respiratory failure," exact="septic shock," post="and/or multiple organ dysfunction or failure. Common clinical laboratory"/>
 <result pre="multiple organ dysfunction or failure. Common clinical laboratory findings comprise" exact="leucopenia" post="and lymphopenia. In particular lymphopenia is one of the"/>
 <result pre="Common clinical laboratory findings comprise leucopenia and lymphopenia. In particular" exact="lymphopenia" post="is one of the key feature of COVID-19 disease"/>
 <result pre="particular lymphopenia is one of the key feature of COVID-19" exact="disease" post="(12). Lactate dehydrogenase and creatinine kinase are elevated, too."/>
 <result pre="D-dimer that should be considered as a marker of worsen" exact="disease" post="(12). Based on the current evidence, most of the"/>
 <result pre="critical condition, particularly the older subjects and those patients with" exact="chronic" post="underlying multimorbidity. The negative progression of disease tends to"/>
 <result pre="those patients with chronic underlying multimorbidity. The negative progression of" exact="disease" post="tends to be faster in older people that are"/>
 <result pre="people that are at higher risk to suddenly develop an" exact="acute respiratory distress syndrome" post="(ARDS). Other less common complications are arrhythmia, septic shock,"/>
 <result pre="that are at higher risk to suddenly develop an acute" exact="respiratory" post="distress syndrome (ARDS). Other less common complications are arrhythmia,"/>
 <result pre="at higher risk to suddenly develop an acute respiratory distress" exact="syndrome" post="(ARDS). Other less common complications are arrhythmia, septic shock,"/>
 <result pre="respiratory distress syndrome (ARDS). Other less common complications are arrhythmia," exact="septic shock," post="acute kidney injury, acute cardiac injury, liver dysfunction and"/>
 <result pre="syndrome (ARDS). Other less common complications are arrhythmia, septic shock," exact="acute" post="kidney injury, acute cardiac injury, liver dysfunction and secondary"/>
 <result pre="(ARDS). Other less common complications are arrhythmia, septic shock, acute" exact="kidney injury," post="acute cardiac injury, liver dysfunction and secondary infection. Diagnosis"/>
 <result pre="less common complications are arrhythmia, septic shock, acute kidney injury," exact="acute" post="cardiac injury, liver dysfunction and secondary infection. Diagnosis Real"/>
 <result pre="shock, acute kidney injury, acute cardiac injury, liver dysfunction and" exact="secondary" post="infection. Diagnosis Real Time PCR (RT-PCR) method is usually"/>
 <result pre="(RT-PCR) method is usually utilized to find causative viruses from" exact="respiratory" post="secretions (13). During the SARS-CoV-2 transmission, RT-PCR has been"/>
 <result pre="During the SARS-CoV-2 transmission, RT-PCR has been considered as the" exact="primary" post="clinical laboratory diagnostic test. Different specific and sensitive assays"/>
 <result pre="assays of the SARSCoV- 2 genome were proposed to detect" exact="viral" post="RNA in clinical specimens. The sampling source and/or the"/>
 <result pre="suggest that RT-PCR test should be interpret with caution (13)." exact="Blood" post="oxygen saturation and blood gas analysis are both essential"/>
 <result pre="both essential to identify patients at higher risk of developing" exact="respiratory" post="distress. Oxygen saturation (SaO2) of 94% or less while"/>
 <result pre="patients are breathing ambient air or a ratio of the" exact="partial" post="pressure of oxygen (PaO2) to the fraction of inspired"/>
 <result pre="oxygen (FiO2) of less than 300 mmHg are suggestive of" exact="respiratory" post="illness. The radiologic presentation of COVID-19 disease is different"/>
 <result pre="are suggestive of respiratory illness. The radiologic presentation of COVID-19" exact="disease" post="is different and sometime suddenly progressing (14). Chest X-ray"/>
 <result pre="an initial screening, but to assess the severity of the" exact="disease" post="and better orientate the therapeutic choices and the use"/>
 <result pre="choices and the use of the intensive care unit, the" exact="chest" post="CT scan is mandatory. Most of patients suffer from"/>
 <result pre="eventually patchy consolidation which are mostly spread in the middle," exact="peripheral" post="and posterior area of the lung (15). Fibrous stripes"/>
 <result pre="consolidation which are mostly spread in the middle, peripheral and" exact="posterior" post="area of the lung (15). Fibrous stripes may emerge"/>
 <result pre="the lung (15). Fibrous stripes may emerge when the SARS-CoV-2" exact="infection" post="is worsened. Radiologists suggest that it is possible classify"/>
 <result pre="glass opacities is the main radiological evidence disseminated in the" exact="lower" post="lobes unilaterally or bilaterally. In second stage, diffuse and"/>
 <result pre="in the lower lobes unilaterally or bilaterally. In second stage," exact="diffuse" post="and bilateral ground glass opacities and consolidation are evident"/>
 <result pre="lower lobes unilaterally or bilaterally. In second stage, diffuse and" exact="bilateral" post="ground glass opacities and consolidation are evident in more"/>
 <result pre="are evident in more than two lobes. In third stage," exact="diffuse" post="ground glass opacities and more dense consolidation are more"/>
 <result pre="the first and the most effective measure of containing SARS-CoV-2" exact="infection" post="(17). Efficient surveillance is the prerequisite for impeding the"/>
 <result pre="particularly vulnerable populations who are at a higher risk for" exact="infection" post="due to living in close proximity to others. Thus,"/>
 <result pre="essential to limit as much as possible the spread of" exact="infection" post="among residents in the longterm care facilities. The geriatricians"/>
 <result pre="immediately identify if the subject suffers of any signs of" exact="respiratory" post="disease, comprising fever, cough or dyspnea, too. For all"/>
 <result pre="potentially correlated to the SARS-CoV-2 infection. Empirical therapy for COVID-19" exact="disease" post="mainly comprise symptomatic and antiviral drugs. The first helpful"/>
 <result pre="the SARS-CoV-2 infection. Empirical therapy for COVID-19 disease mainly comprise" exact="symptomatic" post="and antiviral drugs. The first helpful interventions are important"/>
 <result pre="use of more aggressive therapies, such as non-invasive and invasive" exact="respiratory" post="support are applied (18). Many studies document the potential"/>
 <result pre="of the antiviral drugs (darunavir, lopinavir, and ritonavir) to reduce" exact="viral" post="load and eventually to prevent the respiratory complications (12,"/>
 <result pre="ritonavir) to reduce viral load and eventually to prevent the" exact="respiratory" post="complications (12, 19, 20). Unfortunately, no conclusive results are"/>
 <result pre="no benefit with lopinavirritonavir treatment beyond standard care in hospitalized" exact="adult" post="patients with severe SARS-CoV-2 infection. Remdesivir has potential a"/>
 <result pre="positive result in the treatment of a patient with COVID-19" exact="disease" post="in the United States (22). However, the efficacy of"/>
 <result pre="However, the efficacy of all these antiviral drugs for SARS-CoV-2" exact="infection" post="need to be confirmed by randomized, controlled clinical trials."/>
 <result pre="imaging findings, promoting a virus negative conversion, and shortening the" exact="disease" post="course (23). Chloroquine is utilized to prevent and to"/>
 <result pre="course (23). Chloroquine is utilized to prevent and to treat" exact="malaria" post="and, at the same time, it is used as"/>
 <result pre="is used as an anti-inflammatory drug for the treatment of" exact="rheumatoid arthritis" post="and lupus erythematosus. Some evidences documented that it has"/>
 <result pre="used as an anti-inflammatory drug for the treatment of rheumatoid" exact="arthritis" post="and lupus erythematosus. Some evidences documented that it has"/>
 <result pre="an anti-inflammatory drug for the treatment of rheumatoid arthritis and" exact="lupus erythematosus." post="Some evidences documented that it has potential antiviral properties"/>
 <result pre="monoclonal antibody that inhibits interleukin-6 signaling used as treatment in" exact="rheumatoid arthritis." post="Tocilizumab is administered intravenous experimentally in the treatment of"/>
 <result pre="Tocilizumab is administered intravenous experimentally in the treatment of COVID-19" exact="disease" post="in China and now in Italy with some encouraging"/>
 <result pre="hypothesis that tocilizumab can restore T cell counts in COVID-19" exact="disease" post="patients, by suppressing IL-6 signal, is actually not fully"/>
 <result pre="used to treat Covid-19 patients in order to reduce the" exact="pulmonary" post="inflammation and to prevent the onset of respiratory distress."/>
 <result pre="reduce the pulmonary inflammation and to prevent the onset of" exact="respiratory" post="distress. At present there is no scientific evidence even"/>
 <result pre="use of these agents. The role of geriatrician The COVID-19" exact="disease" post="is certainly an infectious disease with the manifestation of"/>
 <result pre="The role of geriatrician The COVID-19 disease is certainly an" exact="infectious disease" post="with the manifestation of interstitial pneumonia and severe acute"/>
 <result pre="role of geriatrician The COVID-19 disease is certainly an infectious" exact="disease" post="with the manifestation of interstitial pneumonia and severe acute"/>
 <result pre="is certainly an infectious disease with the manifestation of interstitial" exact="pneumonia" post="and severe acute respiratory syndrome (27). The team of"/>
 <result pre="infectious disease with the manifestation of interstitial pneumonia and severe" exact="acute" post="respiratory syndrome (27). The team of medical doctors that"/>
 <result pre="disease with the manifestation of interstitial pneumonia and severe acute" exact="respiratory" post="syndrome (27). The team of medical doctors that is"/>
 <result pre="with the manifestation of interstitial pneumonia and severe acute respiratory" exact="syndrome" post="(27). The team of medical doctors that is mainly"/>
 <result pre="doctors that is mainly involved has preferably been composed by" exact="infectious disease" post="specialists, pneumologists and anesthesiologists. However, given the epidemiology of"/>
 <result pre="that is mainly involved has preferably been composed by infectious" exact="disease" post="specialists, pneumologists and anesthesiologists. However, given the epidemiology of"/>
 <result pre="pneumologists and anesthesiologists. However, given the epidemiology of COVID- 19" exact="disease" post="and the higher risk population for negative outcome, the"/>
 <result pre="most important geriatric syndromes, such as bed rest, sarcopenia, malnutrition," exact="urinary incontinence" post="and delirium (29,30). Finally, geriatricians can act as the"/>
 <result pre="syndromes, such as bed rest, sarcopenia, malnutrition, urinary incontinence and" exact="delirium" post="(29,30). Finally, geriatricians can act as the &quot;sentinel&quot; for"/>
 <result pre="to recognize how reconfigure services to cope. The COVID-19 pandemic" exact="disease" post="has shown the problem of all health care service"/>
 <result pre="the community and in longterm care settings can prevent these" exact="systemic" post="crises and, as a consequence, a new and modern"/>
 <result pre="teams must be integrated into the management of this SARS-CoV-2" exact="infection" post="crisis (32). Conclusion Despite all the aggressive restraint and"/>
 <result pre="Despite all the aggressive restraint and inhibition efforts, the COVID-19" exact="disease" post="continues to increase, and the total number of infected"/>
 <result pre="inhibition efforts, the COVID-19 disease continues to increase, and the" exact="total" post="number of infected patients in the World is growing"/>
 <result pre="aggressively combat the outbreak and dissemination of SARS-CoV-2 infection. COVID-19" exact="disease" post="is a huge risk to large segments of the"/>
 <result pre="concernLancet20203951022347047310.1016/S0140-6736(20)30185-931986257 4.XuHZhongLDengJPengJDanHZengXLiTChenQHigh expression of ACE2 receptor of 2019-nCoV on the" exact="epithelial" post="cells of oral mucosaInt J Oral Sci2020121810.1038/s41368-020-0074-x32094336 5.GuoYRCaoQDHongZSTanYYChenSDJinHJTanKSWangDYYanYThe origin,"/>
 <result pre="J Oral Sci2020121810.1038/s41368-020-0074-x32094336 5.GuoYRCaoQDHongZSTanYYChenSDJinHJTanKSWangDYYanYThe origin, transmission and clinical therapies on" exact="coronavirus disease" post="2019 (COVID-19) outbreak — an update on the statusMil"/>
 <result pre="Oral Sci2020121810.1038/s41368-020-0074-x32094336 5.GuoYRCaoQDHongZSTanYYChenSDJinHJTanKSWangDYYanYThe origin, transmission and clinical therapies on coronavirus" exact="disease" post="2019 (COVID-19) outbreak — an update on the statusMil"/>
 <result pre="epidemic in Wuhan, China: a modelling studyLancet Public Health2020 8.D’AdamoHYoshikawaTOuslanderJGCoronavirus" exact="Disease" post="2019 in Geriatrics and Long-term Care: The ABCDs of"/>
 <result pre="Am Geriatr Soc2020 9.ZhangLMaLSunFTangZChanPA Multicenter Study of Multimorbidity in Older" exact="Adult" post="Inpatients in ChinaJ Nutr Health Aging202024326927610.1007/s12603-020-1311-x32115607 10.HeFDengYLiWCoronavirus disease 2019:"/>
 <result pre="in Older Adult Inpatients in ChinaJ Nutr Health Aging202024326927610.1007/s12603-020-1311-x32115607 10.HeFDengYLiWCoronavirus" exact="disease" post="2019: What we know?J Med Virol2020 11.WuZMcGooganJMCharacteristics of and"/>
 <result pre="Med Virol2020 11.WuZMcGooganJMCharacteristics of and Important Lessons From the Coronavirus" exact="Disease" post="2019 (COVID-19) Outbreak in China: Summary of a Report"/>
 <result pre="Report of 72 314 Cases From the Chinese Center for" exact="Disease" post="Control and PreventionJAMA2020 12.LiQGuanXWuPet al.Early Transmission Dynamics in Wuhan,"/>
 <result pre="China, of Novel Coronavirus-Infected PneumoniaN Engl J Med2020382131199120710.1056/NEJMoa200131631995857 13.ZouLRuanFHuangMet al.SARS-CoV-2" exact="Viral" post="Load in Upper Respiratory Specimens of Infected PatientsN Engl"/>
 <result pre="PneumoniaN Engl J Med2020382131199120710.1056/NEJMoa200131631995857 13.ZouLRuanFHuangMet al.SARS-CoV-2 Viral Load in Upper" exact="Respiratory" post="Specimens of Infected PatientsN Engl J Med2020382121177117910.1056/NEJMc200173732074444 14.ZhangCHuangSZhengFDaiYControversial treatments:"/>
 <result pre="J Med2020382121177117910.1056/NEJMc200173732074444 14.ZhangCHuangSZhengFDaiYControversial treatments: an updated understanding of the Coronavirus" exact="Disease" post="2019J Med Virol2020 15.YangWCaoQQinLet al.Clinical characteristics and imaging manifestations"/>
 <result pre="15.YangWCaoQQinLet al.Clinical characteristics and imaging manifestations of the 2019 novel" exact="coronavirus disease" post="(COVID-19):A multi-center study in Wenzhou city, Zhejiang, ChinaJ Infect202080438839310.1016/j.jinf.2020.02.01632112884"/>
 <result pre="al.Clinical characteristics and imaging manifestations of the 2019 novel coronavirus" exact="disease" post="(COVID-19):A multi-center study in Wenzhou city, Zhejiang, ChinaJ Infect202080438839310.1016/j.jinf.2020.02.01632112884"/>
 <result pre="a comparison with young and middle-aged patientsJ Infect2020 19.ChanJFYuan2KokKHet al.A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
 <result pre="young and middle-aged patientsJ Infect2020 19.ChanJFYuan2KokKHet al.A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
 <result pre="al.Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected" exact="Pneumonia" post="in Wuhan, ChinaJAMA2020 21.CaoBWangYWenDet al.A Trial of Lopinavir-Ritonavir in"/>
 <result pre="ChinaJAMA2020 21.CaoBWangYWenDet al.A Trial of Lopinavir-Ritonavir in Adults Hospitalized with" exact="Severe" post="Covid-19N Engl J Med2020 22.HolshueMLDeBoltCLindquistSet al.First Case of 2019"/>
 <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studiesBiosci Trends2020141727310.5582/bst.2020.0104732074550 24.YanYZouZSunYet al.Anti-malaria drug chloroquine is"/>
 <result pre="Trends2020141727310.5582/bst.2020.0104732074550 24.YanYZouZSunYet al.Anti-malaria drug chloroquine is highly effective in treating" exact="avian influenza" post="A H5N1 virus infection in an animal modelCell Res2013232300210.1038/cr.2012.16523208422"/>
 <result pre="chloroquine is highly effective in treating avian influenza A H5N1" exact="virus infection" post="in an animal modelCell Res2013232300210.1038/cr.2012.16523208422 25.HarrisonCCoronavirus puts drug repurposing"/>
 <result pre="is highly effective in treating avian influenza A H5N1 virus" exact="infection" post="in an animal modelCell Res2013232300210.1038/cr.2012.16523208422 25.HarrisonCCoronavirus puts drug repurposing"/>
 <result pre="26.ChenGWuDGuoWet al.Clinical and immunologic features in severe and moderate Coronavirus" exact="Disease" post="2019J Clin Invest2020 27.LivingstonEBucherKCoronavirus Disease 2019 (COVID-19) in ItalyJAMA2020"/>
 <result pre="in severe and moderate Coronavirus Disease 2019J Clin Invest2020 27.LivingstonEBucherKCoronavirus" exact="Disease" post="2019 (COVID-19) in ItalyJAMA2020 28.Morales-MartínezFEditorial: A Teaching Geriatric HospitalJ"/>
</results>
